Skip to main content
Log in

Assessment of Fatigue in Patients with Chronic Hepatitis C Using the Fatigue Impact Scale

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of this study was to assess the impact of fatigue on the quality of life of patients with chronic hepatitis C (CHC) and to examine its relationship with various parameters of the disease, including viral load. The Fatigue Impact Scale (FIS), a self-report questionnaire, was applied to 92 patients with CHC, and the results were compared to those of an age-matched cohort of 213 healthy blood donors. Fatigue was frequent and disabling, being present in 67% of CHC patients, and the FIS was significantly increased in CHC patients compared to the healthy controls. Fatigue severity was not correlated with the activity of the disease or with the level of viremia. The FIS proved to be a valuable tool to assess this symptom. It should be of help for better evaluation of the clinical spectrum of the disease and should be included in trials assessing the efficacy of therapeutic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Anonymous: Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6:35–47, 1999

  2. Alberti A, Chemello L, Benvegnù L: Natural history of hepatitis C. J Hepatol 31:17–24, 1999

    Google Scholar 

  3. Shakil AO, Conry-Cantilena C, Alter HJ: Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 123:330–337, 1995

    Google Scholar 

  4. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463–1466, 1995

    Google Scholar 

  5. Tong MJ, El-Farra NS: Clinical sequelae of hepatitis C acquired from injection drug use. West J Med 164:399–404, 1996

    Google Scholar 

  6. Kenny-Walsh E for the Irish Hepatology Study Group: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 340:1228–1233, 1999

    Google Scholar 

  7. Barkhuizen A, Rosen HR, Wolf S, flora K, Benner K, Bennett RM: Musculoskeletal pain and fatigue are associated with chronic hepatitis C. A report of 239 hepatology clinic patients. Am J Gastroenterol 94:1355–1360, 1999

    Google Scholar 

  8. EASL International Consensus Conference on Hepatitis C. Consensus statement. J Hepatol 31:3–8, 1999

    Google Scholar 

  9. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ: The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21:9–14, 1994

    Google Scholar 

  10. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18:S79–S83, 1994

    Google Scholar 

  11. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J: Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 95:760–767, 2000

    Google Scholar 

  12. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981

    Google Scholar 

  13. Hoofnagle JH. Hepatitis C: The clinical spectrum of the disease. Hepatology 26:15S-20S, 1997

    Google Scholar 

  14. Merican I, Sherlock S, McIntyre N, Dusheiko GM: Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med 86:119–125, 1993

    Google Scholar 

  15. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J: Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 11:833–838, 1999

    Google Scholar 

  16. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ: Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res 49:311–317, 2000

    Google Scholar 

  17. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL: Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 16:334–343, 1994

    Google Scholar 

  18. Carithers RL, Sugano D, Bayliss M: Health assessment for chronic HCV infection. Results of quality of life. Dig Dis Sci 41:75S-80S, 1996

    Google Scholar 

  19. Hunt CM, Dominitz JA, Philips Bute B, Waters B, Blasi U, Williams DM: Effect of interferon-α treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci 42:2482–2486, 1997

    Google Scholar 

  20. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE: A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 7:39–55, 1998

    Google Scholar 

  21. Foster GR, Goldin RD, Thomas HC: Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27:209–212, 1998

    Google Scholar 

  22. Bonkovsky HL, Woolley JM, Consensus Interferon Study Group: Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 29:264–270, 1999

    Google Scholar 

  23. Ware JE, Bayliss MS, Mannocchia M, Davis GL: Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. Hepatology 30:550–555, 1999

    Google Scholar 

  24. Neary MP, Cort S, Bayliss MS, Ware JE: Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients. Semin Liver Dis 19:77–85, 1999

    Google Scholar 

  25. McHutchinson JG, Ware JE, Bayliss MS, Pianko S, Albrecht JK, Cort S, Yang I, Neary MP: The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 34:140–147, 2001

    Google Scholar 

  26. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD: Evidence for a cerebral effect of the hepatitis C virus. Lancet 358:38–39, 2001

    Google Scholar 

  27. Gershon AS, Margulies M, Gorczynski RM, Heathcote EJ: Serum cytokine values and fatigue in chronic hepatitis C infection. J Viral Hepat 7:397–402, 2000

    Google Scholar 

  28. Jones EA: Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. Med Hypotheses 57:133–134, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassoun, Z., Willems, B., Deslauriers, J. et al. Assessment of Fatigue in Patients with Chronic Hepatitis C Using the Fatigue Impact Scale. Dig Dis Sci 47, 2674–2681 (2002). https://doi.org/10.1023/A:1021040702370

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021040702370

Navigation